.png)
.png)
Latest news from BIA
CEO Update | 17 January 2022
The UK sector was out in virtual force at the annual JP Morgan Healthcare conference held virtually last week. It was great to see UK companies at the forefront of the global themes. I’m really looking forward to seeing many of you on 27 January as we gather in person to celebrate the achievements of the sector at the BIA Gala Dinner. I’m glad to confirm that Science Minister George Freeman MP will be our pre dinner keynote speaker.
Guest blog: Ochre Bio - Love Your Liver Month
Love Your Liver is a national awareness month devoted to liver health awareness and giving people the key steps needed to keep their liver healthy. We spoke to Ochre Bio, a liver medicines company, to find out what they're up to in this space.
CEO Update | 10 January 2022
Welcome to the first CEO blog of 2022, one I’m delighted not to have penned from an overpriced hotel room in San Francisco – my normal place of work this time of year. A new year normally means a fresh start, but it seems the year will again be dominated by how governments and global economies will respond to the COVID-19 pandemic.
CEO Update | 20 December 2021
Best wishes of the season from everyone at BIA. It has been fantastic working with you in 2021 and we would like to take this opportunity to thank you for your support throughout the year. For those following the implications of the Northern Ireland Protocol discussions with regard to medicines, more information here.
UK Life Sciences innovation highlighted by the Prime Minister at global healthcare investment conference
• Multiple UK deals and investments highlighted at key year opening global life science investment conference • Prime Minister Boris Johnson makes keynote address, highlighting strength of UK ecosystem to global investment community
A new era for the BIA as it announces new Chair and appointments to the Board plus key new hires
Following the BIA Annual General Meeting, the Association has announced its next Chair and members who have been elected to its Board of Directors. The AGM took place on Tuesday 19th October and the new board members were voted for by the BIA’s membership in the weeks leading up to the meeting
BIA reacts to £400m investment in the UK by Fujifilm Diosynth Biotechnologies
Reacting to news that Fujifilm Diosynth Biotechnologies will be investing £400m into their UK manufacturing operation Steve Bates OBE, Chief Executive of the Bioindustry Association said
The BioIndustry Association and Kidney Research UK announce new 2022 Charity of the Year partnership
The BioIndustry Association (BIA) is delighted to announce Kidney Research UK as its charity partner for 2022. Kidney disease affects three million people in the UK with 20 people developing kidney failure each day. The charity undertakes research to end kidney disease, offering kidney patients and their families hope for the future. The partnership aims to raise funds, increase awareness of kidney health, and promote kidney research to the life sciences ecosystem.
The Oxford Science Park appoints Jitesh Patel as Development Manager
New role enables accelerated delivery of buildings for existing & new occupiers
Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)
Pneumagen is a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
Funds will allow for a rapid transition through pre-commercialization to market launch
PhoreMost expands into new facility at Unity Campus, Cambridge, UK
New state-of-the-art facility has been designed to support PhoreMost’s phenotypic screening expertise. Investment in new headquarters and equipment forms part of ongoing company growth plans.
Here's a selection of featured BIA publications. See Resources Hub
BIA submision to the S&T Select Committee inquiry on improving diversity in STEM
The BIA has responded to the Science & Technology Select Committee's consultation on diversity in STEM.
BIA submission to the UK IPO's consultation on AI and IP
The BIA has responded to the UK Intellectual Property Office’s consultation on copyright in works made by AI, text and data mining using copyright material, and patents for inventions devised by AI.
BIA response to consultation on proposals for change to NICE's methods, processes and topic selection
The BIA has responded to a consultation on proposals for change to NICE's methods, processes and topic selection.
Influencing and shaping our sector | BIA update: July to October 2021
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from July to October 2021.
